@article{4061da8cdbd74e359a61758214d7b26b,
title = "Kidney injury biomarkers during exposure to tenofovir-based preexposure prophylaxis",
abstract = "We previously reported a higher incidence of non-albumin proteinuria and a small but significant decline in estimated glomerular filtration rate (eGFR) among HIV-negative adults randomized to emtricitabine/tenofovir disoproxil fumarate preexposure prophylaxis (FTC/TDF PrEP) versus placebo. In a nested case - control study among participants randomized to FTC/TDF PrEP, established kidney injury biomarkers measured at 12 months were not significantly different between participants who subsequently experienced one of these kidney endpoints and randomly selected controls who did not.",
author = "Nickolas, {Thomas L.} and Jonathan Barasch and Mugwanya, {Kenneth K.} and Branch, {Andrea D.} and Renee Heffron and Valentine Wanga and Mugo, {Nelly R.} and Allan Ronald and Connie Celum and Deborah Donnell and Baeten, {Jared M.} and Wyatt, {Christina M.}",
note = "Funding Information: The Partners PrEP Study was funded by the Bill and Melinda Gates Foundation (OPP47674). This work was also supported by the National Institutes of Health, National Institute for Diabetes, Digestive, and Kidney Diseases (R01DK100272 and R01DK112258), the National Institute of Child Health and Human Development (R01HD089843), and the National Institute for Allergy and Infectious Disease (P30AI027757). Publisher Copyright: {\textcopyright} 2021 Lippincott Williams and Wilkins. All rights reserved.",
year = "2021",
month = jun,
day = "1",
doi = "10.1097/QAD.0000000000002865",
language = "English",
volume = "35",
pages = "1147--1149",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins Ltd.",
number = "7",
}